BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Summary

Adult patients with chronic lymphocytic leukaemia who experience a relapse after at least two prior treatment regimens may be enrolled in this trial. The trial will examine whether monotherapy with BI 836826 is safe and tolerable at escalating dose levels.

Timeline

Start

2011-02-11

Primary completion

2017-05-30

Completion

2017-07-10

Drugs

Indications